PART I . Overview DBV Technologies is a late-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT, our proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). We have generated significant data demonstrating that Viaskin patch...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001628280-26-021504 | EDGAR | 99K words |
| 2025-04-11 | 2024-12-31 | 0001613780-25-000006 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0001193125-24-062357 | EDGAR | — |
| 2023-03-02 | 2022-12-31 | 0001193125-23-058309 | EDGAR | — |
| 2022-03-09 | 2021-12-31 | 0001193125-22-070467 | EDGAR | — |
| 2021-03-17 | 2020-12-31 | 0001193125-21-084223 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-16 | 2026-06-30 | 0001628280-26-048453 | EDGAR | — |
| 2025-10-28 | 2025-09-30 | 0001628280-25-046809 | EDGAR | 22K words |
| 2025-07-29 | 2025-06-30 | 0001613780-25-000016 | EDGAR | — |
| 2025-04-30 | 2025-03-31 | 0001613780-25-000011 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001613780-24-000007 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0001193125-24-188853 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001193125-24-133228 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001193125-23-267271 | EDGAR | — |
| 2023-07-31 | 2023-06-30 | 0001193125-23-199175 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001193125-23-136030 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001193125-22-277052 | EDGAR | — |
| 2022-08-01 | 2022-06-30 | 0001193125-22-208808 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-16 | 0001193125-26-306222 | EDGAR | — |
| 2026-03-26 | 0001193125-26-126671 | EDGAR | 2K words |
| 2026-03-02 | 0001193125-26-084251 | EDGAR | — |
| 2026-01-20 | 0001193125-26-015592 | EDGAR | — |
| 2025-12-16 | 0001193125-25-320901 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258780 | EDGAR | — |
| 2025-10-29 | 0001193125-25-253968 | EDGAR | — |
| 2025-09-18 | 0001193125-25-207507 | EDGAR | — |
| 2025-09-05 | 0001193125-25-197277 | EDGAR | — |
| 2025-07-29 | 0001193125-25-168148 | EDGAR | — |
318 total filings indexed. 290 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001613780 |
| Ticker | DBVT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | I0 |
| Website | https://www.dbv-technologies.com |
| Listed | 2014-10-22 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DBVT (~200 tokens, structured JSON with cryptographic provenance)